Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Gil

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 19, 2025
Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensusDolores Isla, Esther Conde, Atocha Romero, et al.
Frontiers in Immunology|May 25, 2026
A blood-based immune-suppressive index stratifies immunotherapy outcomes in advanced NSCLCLuca Lalli, Veronica Huber, Agata Cova, et al.
Irish Journal of Medical Science|June 10, 2020
Non fluoroscopic ablation of different arrhythmic structures in an electrophysiology unit. Assessment of efficiency and securityIgnacio Gil-Ortega, Alfredo Serna-Berná, Antonio Javier Trujillo-Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2020
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical PracticeIñaki Eguren-Santamaria, Miguel F Sanmamed, Sarah B Goldberg, et al.
Current Drug Targets|December 17, 2014
The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?Francesco Passiglia, Nele Van Der Steen, Luis Raez, et al.
International Journal of Molecular Sciences|February 13, 2025
Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate CancerFrancisco Porcel-Pastrana, Antonio J Montero-Hidalgo, Miguel E G-García, et al.
Disease Markers|February 28, 2019
The Dynamic Use of <i>EGFR</i> Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer PatientsMónica Macías, Estibaliz Alegre, Gorka Alkorta-Aranburu, et al.
Onkologie|October 10, 2009
Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancerJoaquim Bosch-Barrera, Miren Gaztañaga, Jaime Ceballos, et al.
Pathogens (Basel, Switzerland)|May 7, 2025
Integrated Control of <i>Aedes albopictus</i> in a Residential Area Through a Community-Based Approach: NESCOTIGER, a Large-Scale Field Trial in Valencia, SpainMarcos López-de-Felipe, Pedro María Alarcón-Elbal, Isaac García-Masiá, et al.
Clinical Genitourinary Cancer|November 14, 2012
Clinical management of small-cell carcinoma of the urinary tract: a 10-year single-center's experienceOmar E Carranza, Eduardo Castañón, Luis E Abella, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 19, 2025
Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensusDolores Isla, Esther Conde, Atocha Romero, et al.
Frontiers in Immunology|May 25, 2026
A blood-based immune-suppressive index stratifies immunotherapy outcomes in advanced NSCLCLuca Lalli, Veronica Huber, Agata Cova, et al.
Irish Journal of Medical Science|June 10, 2020
Non fluoroscopic ablation of different arrhythmic structures in an electrophysiology unit. Assessment of efficiency and securityIgnacio Gil-Ortega, Alfredo Serna-Berná, Antonio Javier Trujillo-Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2020
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical PracticeIñaki Eguren-Santamaria, Miguel F Sanmamed, Sarah B Goldberg, et al.
Current Drug Targets|December 17, 2014
The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?Francesco Passiglia, Nele Van Der Steen, Luis Raez, et al.
International Journal of Molecular Sciences|February 13, 2025
Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate CancerFrancisco Porcel-Pastrana, Antonio J Montero-Hidalgo, Miguel E G-García, et al.
Disease Markers|February 28, 2019
The Dynamic Use of <i>EGFR</i> Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer PatientsMónica Macías, Estibaliz Alegre, Gorka Alkorta-Aranburu, et al.
Onkologie|October 10, 2009
Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancerJoaquim Bosch-Barrera, Miren Gaztañaga, Jaime Ceballos, et al.
Pathogens (Basel, Switzerland)|May 7, 2025
Integrated Control of <i>Aedes albopictus</i> in a Residential Area Through a Community-Based Approach: NESCOTIGER, a Large-Scale Field Trial in Valencia, SpainMarcos López-de-Felipe, Pedro María Alarcón-Elbal, Isaac García-Masiá, et al.
Clinical Genitourinary Cancer|November 14, 2012
Clinical management of small-cell carcinoma of the urinary tract: a 10-year single-center's experienceOmar E Carranza, Eduardo Castañón, Luis E Abella, et al.
Pageof 15